VOMIBYE INJ contains Ondansetron HCl 4 mg/2 mL, a parenteral antiemetic formulated for effective control of nausea and vomiting in appropriate clinical settings. A practical PCD Pharma Injectable Anti-Emetic product.
Prevention and treatment of nausea and vomiting in appropriate clinical settings.
Yes, when clinically indicated.
Administer under healthcare supervision. Use cautiously in patients with heart-rhythm abnormalities or medicines that prolong QT interval.
Headache, constipation, dizziness and fatigue may occur; QT prolongation is an important uncommon risk.
VOMIBYE INJ: Ondansetron selectively blocks 5-HT3 serotonin receptors involved in the vomiting reflex, providing potent antiemetic action.
